Family Office Of America (FOFA) Cash from Financing Activities (2024 - 2025)

Family Office Of America (FOFA) posted Cash from Financing Activities of $50000.0 for Q4 2025, down 80.77% sequentially from $260000.0 in Q3 2025.

Family Office Of America (FOFA) Cash from Financing Activities (2024 - 2025) Analysis & Trends

Family Office Of America has reported Cash from Financing Activities for 2 years, with the latest figure at $50000.0 in Q4 2025.

Quarterly Cash from Financing Activities changed N/A year-over-year to $50000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $965000.0 (up 859.96% YoY) and the FY2025 annual result came in at $965000.0, up 859.96% from the prior year.
Cash from Financing Activities fell to $50000.0 in Q4 2025 per FOFA's latest filing, from $260000.0 in the prior quarter.
Over five years, Cash from Financing Activities peaked at $575000.0 in Q1 2025 and troughed at $525.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-3.52 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	-95.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-888.00 Mn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	-410.00 Mn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-300,000.00
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-607.30 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	-236.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-1.34 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-213.50 Mn
10	Family Office Of America	27.84 Mn	27.20 Mn	532,674.00	-

Download Data